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Abstract
Cortical superficial siderosis (cSS), also referred to as sulcal siderosis, is a neurological
condition characterized by hemosiderin subpial deposits in the cortical sulci over the
convexities of cerebral hemispheres. These deposits are further found sparingly in the spinal
cord, brainstem, and cerebellum. Patients typically present with transient focal neurological
symptoms that make cSS challenging to differentiate from other acute neurological processes
such as transient ischemic attacks (TIA), focal seizures, and acute convexity subarachnoid
hemorrhage (cSAH). This condition is presently recognized as a characteristic feature of the
age-associated disorder referred to as cerebral amyloid angiopathy (CAA). This paper describes
a patient who presented with transient neurologic symptoms, first suspected to be secondary to
acute subarachnoid hemorrhage (SAH), found to have cSS and cerebral amyloid angiopathy.
Categories: Medical Education, Neurology, Neurosurgery
Keywords: superficial siderosis, amyloid angiopathy, intracerebral hemorrhage, subarachnoid
hemorrhage, boston criteria
Introduction
Siderosis, which is obtained from sideros, a Greek word, refers to the accumulation of
compounds containing iron in body tissues. Superficial siderosis occurs when blood breakdown
products such as iron and hemosiderin are deposited in the pial and subpial regions of the
brain. Superficial siderosis is further subclassified into classical superficial siderosis with
clinical features including ataxia, sensorineural hearing loss and cognitive decline that is
attributed to blood residue deposition primarily in the infratentorial regions and spinal cord [1-
2]. A second form called cortical superficial siderosis (cSS) has been recently described as
siderosis limited to the supratentorial region and the convexities of cerebral hemispheres, that
may manifest as episodes of transient focal neurological episodes. It may be an indicator of
increased future intracerebral hemorrhage (ICH) risk in patients with cerebral amyloid
angiopathy (CAA) [2]. Notably, the most common clinical manifestation of CAA is spontaneous
ICH. Despite this possible risk association, cSS itself is a separate entity that may resemble
subarachnoid hemorrhage on brain imaging. Further, cSS has significant relevance in
neurovascular, epilepsy, and memory-based services.
Clinical studies have demonstrated that cSS is caused by repeated episodes of convexity
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subarachnoid hemorrhage (cSAH) from weakened leptomeningeal vessels affected by CAA. As
acute blood products are gradually degraded, there is a deposition of residues, such as
hemosiderin, in the superficial cortical layers. The neuropathologic mechanisms underlying cSS
remain unclear [3-4]. The ability to identify cSS may prove helpful in risk stratification of
patients and further clinical practice and management, especially regarding antithrombotic and
anticoagulant use. The most common diagnosis and assessment of superficial siderosis is
magnetic resonance imaging (MRI) where the folia and cerebellar vermis are the best areas for
locating the deposition. In this paper, we describe the case of an individual who presented with
transient neurologic symptoms initially suspected to be secondary to acute SAH found to have
cSS and CAA.
Case Presentation
A 75-year-old right-handed female with no significant past medical history presented to an
outside facility after having several episodes of right arm numbness and weakness.
Additionally, perioral numbness and occasional word-finding difficulties prompted an MRI of
the brain, which revealed a left frontal convexity and right parietal convexity SAH. The patient
underwent catheter cerebral angiography that showed no evidence of aneurysm. She was
initiated on Keppra for presumed focal seizures.
After discharge, the patient had recurrent symptoms, and another brain MRI showed no new
areas of SAH. Neurosurgery was consulted for suspected aneurysms, and a cerebral angiogram
was carried out, which showed no acute pathology. MRI of the brain revealed bilateral cortical
superficial siderosis with associated bilateral occipital, posterior Sylvian and left temporal
siderosis (Figure 1 A-D). There were also microbleeds from areas of amyloid angiopathy in the
left internal capsule, which were consistent with her right-sided symptoms, and it was
determined that the patient’s transient recurrent neurological clinical presentations were the
sequelae of her underlying amyloid angiopathy and cortical superficial siderosis. The patient
was advised to refrain from anticoagulant and antiplatelet use due to an increased risk of
intracerebral hemorrhaging in the setting of both amyloid angiopathy and aneurysm.
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FIGURE 1: Detection of cortical superficial siderosis on MRI
Distribution of cSS is supratentorial with no intraparenchymal involvement as is seen in ICH.
A. cSS; B. bilateral temporal; C. left temporal; D. right temporal and left occipital lobes
cSS, cortical superficial siderosis; ICH, intracerebral hemorrhage
Discussion
The clinical relevance of cSS is still being investigated, but its association with CAA and ICH
risk is becoming better understood. A recent study demonstrated that cSS was found by MRI
investigation in 44.1% of patients with probable CAA based on the modified Boston criteria
(Table 1) [5], that presented with cognitive impairment and transient focal neurological
symptoms. Further, cSS progression was found to independently predict increased symptomatic
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ICH risk [6].
 Modified Boston Criteria
Definite CAA
Full post-mortem examination demonstrating:
- Lobar, cortical or corticosubcortical hemorrhage
- Severe CAA with vasculopathy
- Absence of another diagnostic lesion
Probable CAA with supporting
pathology
Clinical data and pathological tissue (evaluated) hematoma or cortical biopsy)
demonstrating:
- Lobar, cortical or corticosubcortical hemorrhage
- Some degree of CAA in the specimen
- Absence of another diagnostic lesion
Probable CAA
Clinical data and MRI or CT demonstrating:
- Multiple hemorrhages restricted to lobar, cortical or corticosubcortical regions
- Single lobar, cortical, or corticosubcortical hemorrhage and focal or disseminated
superficial siderosis
- Age ≥55
- Absence of other cause of hemorrhage or superficial siderosis
Possible CAA
Clinical data and MRI or CT demonstrating:
- Single lobar, cortical or corticosubcortical hemorrhage, or
- Focal or disseminated superficial siderosis
- Age ≥55
- Absence of other cause of hemorrhage or superficial siderosis
TABLE 1: Modified Boston Criteria
CAA, cerebral amyloid angiopathy
As cSS is most often found in patients that present with transient focal neurological episodes,
that may be attributed to TIA, the ability to differentiate these entities is paramount [6-7].
Patients thought to have TIA are often placed on antithrombotics for secondary stroke
prevention and given the aforementioned increased ICH risk in patients with cSS, this
management approach would be suboptimal as it would increase the risk of bleeds and
potential patient morbidity.
Though cSS association with CAA and ICH risk is being studied, there have not been numerous
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investigations into cSS being misidentified as acute cSAH or how this impacts patient
management or outcomes. As is exemplified with our patient, cSS being attributed to an acute
cSAH may prompt unnecessary interventions for patients. For example, cerebral angiography is
often undertaken to find a source of bleeding, but this is typically unrewarding possibly due to
the slow and intermittent bleeding associated with superficial siderosis in general or the
chronic ongoing resolution of a prior bleed [8]. Drawing from the pathophysiology of cSS, a
single hemorrhage is insufficient to cause the condition, thus profound diagnosis should be
conducted including establishing the location of the deposition. Therefore, it is essential to be
able to identify cSS in patients when evaluating their ischemic stroke or hemorrhage risk and
developing management plans. Effective diagnosis and management will enhance the quality
of patient outcomes and increase patient safety. 
The clinical presentations of patients with cSS are typically recurrent transient focal
neurological episodes, as was the case with our patient. These presentations are characterized
as lasting from minutes to hours and include episodes of paresthesias, numbness, or weakness
that typically resolve over a short time period. Essential to note is that these symptoms are
distinct from those of the typical SAH patient who presents with the characteristic thunderclap
headache. Currently, it is difficult to distinguish the frequency of patients presenting with
transient focal neurological episodes that are secondary to CAA, cSS, or cSAH versus a transient
ischemic attack (TIA) as few centers routinely obtain blood-sensitive MRI sequences which are
necessary to detect these underlying processes [6]. Further, since cSS is not a commonly
diagnosed radiographic finding, a better understanding of distinguishing characteristics, as
shown in Table 2, could increase the likelihood of cSS being identified. The MRI appearance of
cSS is a result of deposition of blood breakdown products that result in a curvilinear “track-
like” pattern along the cortical surface [9].
MRI Mode cSS Acute cSAH
T1 Low signal* High signal
T2 Low signal** High signal
Gradient Echo Low signal with blooming High signal
Susceptibility Weighted Imaging Low signal with blooming** High signal
Location of blood products - Superficial layers of the cerebral cortex - Subarachnoid Space Subarachnoid Space
TABLE 2: Differences in presentation of cSS and acute cSAH on MRI
*cSS is not typically detected on T1 weighted imaging unless there has been a subacute bleed [6].
**Blood breakdown residues cause local magnetic field inhomogeneity that leads to loss of signal in T2 and SWI sequences [7].
cSS, cortical superficial siderosis; cSAH, convexity subarachnoid hemorrhage; SWI, susceptibility-weighted imaging
In patients such as ours, with recurrent unexplained transient focal neurological episodes, it
could be beneficial in evaluation to obtain blood-sensitive MRI sequences to elucidate the
etiology of the patients’ symptoms. Additionally, future studies into the pathophysiology,
pathogenesis, and progression of cSS, as well as accumulation of evidence-based data to guide
therapy for patients found to have cSS will influence our ability to risk-stratify patients as well
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as inform our use of antithrombotic and anticoagulant agents in developing effective and
patient-centered interventions for the management of these patients.
Conclusions
cSS is characterized by blood breakdown products, such as hemosiderin, being deposited in the
cortical sulci. It is difficult to identify because it presents like other neurological processes with
transient focal neurological symptoms and requires blood-sensitive MRI for an accurate
diagnosis. Given recent studies demonstrating the association of cSS with intracranial
hemorrhage, a better understanding of the mechanisms of cSS will influence our treatment
approach, especially in the utilization of antithrombotic and anticoagulant agents for improved
patient outcomes.
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